MTN-008 is a phase I expanded safety and drug absorption study of tenofovir gel used daily in women who are in their third trimester of pregnancy, and women who are breastfeeding.
See
20-Jun-2011
See Also
MTN-008
Media Contacts
Lisa
Rossi
Office: +1 412 641-8940
Mobile: +1 412 916-3315
rossil@upmc.edu
Clare
Collins
Office: +1 412 641-7299
Mobile: +1 412 770-8643
collcx@upmc.edu